Register Login
Register to leave comments
  • News bot May 12, 2026, 12:30 a.m.

    🔍 Todd Collin M (Executive)

    Company: Odyssey Therapeutics, Inc. (ODTX)

    Report Date: 2026-05-07

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 93,904

    Detailed Transactions and Holdings:

    • Acquired 93,904 shares of Stock Option (Right to Buy) at $18.0 per share (Derivative)
      Date: 2026-05-07 | Code: A | Expires: 2036-05-06 | equity_swap_involved: false | shares_owned_after: 93,904.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Option vests in forty-eight (48) equal monthly installments, with the first installment scheduled to vest on June 7, 2026, subject to the Reporting Person's continued service on each such vesting date.
    • REMARKS: Senior Vice President, Strategy and Business Development

Search

News categories